[go: up one dir, main page]

MX2017015674A - Suplemento dietetico. - Google Patents

Suplemento dietetico.

Info

Publication number
MX2017015674A
MX2017015674A MX2017015674A MX2017015674A MX2017015674A MX 2017015674 A MX2017015674 A MX 2017015674A MX 2017015674 A MX2017015674 A MX 2017015674A MX 2017015674 A MX2017015674 A MX 2017015674A MX 2017015674 A MX2017015674 A MX 2017015674A
Authority
MX
Mexico
Prior art keywords
dietetic supplement
dietetic
supplement
bifidobacterium
genera
Prior art date
Application number
MX2017015674A
Other languages
English (en)
Other versions
MX382895B (es
Inventor
Galaffu Nicola
Alberto Habeych Narvaez Edwin
Silva Zolezzi Irma
Moille Sophie
BOURQUI Bertrand
Colombo MOTTAZ Sara
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53434227&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2017015674(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2017015674A publication Critical patent/MX2017015674A/es
Publication of MX382895B publication Critical patent/MX382895B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición oral que comprende al menos una bacteria probiótica seleccionada de los géneros: Lactobacillus, Bifidobacterium y Bacillus, y pirofosfato férrico.
MX2017015674A 2015-06-11 2016-06-09 Suplemento dietético. MX382895B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15171552 2015-06-11
PCT/EP2016/063170 WO2016198528A1 (en) 2015-06-11 2016-06-09 Dietary supplement

Publications (2)

Publication Number Publication Date
MX2017015674A true MX2017015674A (es) 2018-04-18
MX382895B MX382895B (es) 2025-03-13

Family

ID=53434227

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017015674A MX382895B (es) 2015-06-11 2016-06-09 Suplemento dietético.

Country Status (9)

Country Link
US (2) US11660322B2 (es)
EP (1) EP3307290B2 (es)
CN (1) CN107690332A (es)
BR (1) BR112017023636B1 (es)
CA (1) CA2983685A1 (es)
ES (1) ES2803175T5 (es)
MX (1) MX382895B (es)
PH (1) PH12017502042A1 (es)
WO (1) WO2016198528A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018115985A1 (en) 2016-12-22 2018-06-28 Wickens Kristen Lee Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
EP4136985A1 (en) * 2016-12-22 2023-02-22 University of Otago Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
RU2763172C2 (ru) 2017-06-02 2021-12-28 Юниверсити Оф Отаго Применение молочнокислых бактерий для лечения или предупреждения по меньшей мере одного состояния из числа послеродовой депрессии и послеродовой тревожности
IT201800004072A1 (it) * 2018-03-29 2019-09-29 Smart Farma S R L Composizione alimentare come coadiuvante nello sviluppo della microflora intestinale e del sistema immunitario dei neonati
MY210247A (en) 2018-06-22 2025-09-04 Fonterra Cooperative Group Ltd Use of polar lipids to treat or prevent gestational diabetes mellitus
JP7021396B2 (ja) * 2020-01-31 2022-02-16 太陽化学株式会社 鉄含有組成物
EP4292442A1 (en) * 2022-06-13 2023-12-20 Ekaterra Research and Development UK Limited An iron fortified instant beverage composition
TW202537527A (zh) * 2024-03-28 2025-10-01 日商東洋新藥股份有限公司 飲料
CN118020942A (zh) * 2024-04-10 2024-05-14 鑫隽益(上海)生物科技有限公司 一种女性孕期补铁复合益生菌粉剂及其制备方法
WO2025242791A1 (en) 2024-05-23 2025-11-27 Société des Produits Nestlé S.A. Composition comprising iron-containing green plant material concentrate in combination with compounds sensitive to oxidation or ironintolerant microorganisms

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3159931B2 (ja) 1997-02-14 2001-04-23 株式会社ヤクルト本社 鉄分を強化した発酵乳およびその製造方法
EP1142988B1 (en) * 1999-01-14 2006-11-22 Gold Kosan Co. Ltd Novel microorganism and use thereof
CA2281463A1 (en) 1999-08-26 2001-02-26 Stanley H. Zlotkin Composition comprising micronutrients in combination with prebiotics, probiotics, and synbiotics
CA2347891A1 (en) * 1999-08-26 2001-03-08 Stanley H. Zlotkin Composition comprising micronutrients in combination with prebiotics, probiotics, and/or synbiotics
WO2007002572A2 (en) * 2005-06-24 2007-01-04 N-Zymeceuticals, Inc. Nattokinase for reducing whole blood viscosity
EP2124584B1 (en) * 2007-03-20 2010-07-14 Unilever N.V. Method of manufacturing a cultured edible product comprising omega-3 polyunsaturated fatty acids and iron
PL2124585T3 (pl) * 2007-03-20 2011-04-29 Unilever Nv Sposób wytwarzania jadalnego produktu zawierającego owoce, omega-3 polinienasycone kwasy tłuszczowe i żelazo
EP2011506A1 (en) * 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
ES2550499T3 (es) * 2008-03-28 2015-11-10 Nestec S.A. Probióticos de uso en mamíferos hembra gestantes para aumentar la inmunidad de sus crías
EP2110028A1 (en) 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
EP2258217A1 (en) 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Children
CN101601421A (zh) * 2009-07-04 2009-12-16 内蒙古蒙牛乳业（集团）股份有限公司 一种强化铁和锌的儿童酸奶及其制备方法
EP2289527B1 (en) 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
WO2011114916A1 (ja) 2010-03-18 2011-09-22 森永乳業株式会社 貧血の予防又は治療用組成物
CN101869141B (zh) 2010-05-25 2012-07-25 北京三元食品股份有限公司 强化铁、锌和钙的咸味酸奶及其加工方法
WO2012017893A1 (ja) 2010-08-02 2012-02-09 三井化学株式会社 廃棄物処理システム
CN102144670A (zh) 2011-02-28 2011-08-10 澳优乳业（中国）有限公司 一种益生菌配方奶粉及其制造方法
EP2534959A1 (en) 2011-06-14 2012-12-19 Nestec S.A. Wholegrain cereal and liver disorders
US20130095189A1 (en) 2011-10-14 2013-04-18 Zeina Jouni Composition and method of phytonutrients for metabolic programming effects
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions
KR102008043B1 (ko) 2012-03-21 2019-08-06 가부시키가이샤 야쿠르트 혼샤 피로인산철 조성물
CN102940037B (zh) 2012-05-23 2014-06-04 四川农业大学 制备共沉淀氢氧化铁酸奶的方法
CN103988863B (zh) * 2013-02-20 2016-12-28 湖北智权专利技术应用开发有限公司 一种具有保健功能的低热量、高营养烘焙食品
WO2014148886A1 (en) * 2013-03-22 2014-09-25 N.V. Nutricia Fermented nutrition high in lactose with increased iron bioavailability
US9241923B2 (en) * 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
JP2017512068A (ja) 2014-02-17 2017-05-18 ネステク ソシエテ アノニム マイトフュージンの方法及び使用

Also Published As

Publication number Publication date
US11660322B2 (en) 2023-05-30
BR112017023636A2 (pt) 2018-07-17
EP3307290A1 (en) 2018-04-18
WO2016198528A1 (en) 2016-12-15
CN107690332A (zh) 2018-02-13
US20180133267A1 (en) 2018-05-17
PH12017502042A1 (en) 2018-04-23
ES2803175T5 (en) 2025-06-09
US20230381252A1 (en) 2023-11-30
ES2803175T3 (es) 2021-01-25
CA2983685A1 (en) 2016-12-15
MX382895B (es) 2025-03-13
BR112017023636B1 (pt) 2021-11-03
EP3307290B1 (en) 2020-04-15
US12397026B2 (en) 2025-08-26
EP3307290B2 (en) 2025-03-05

Similar Documents

Publication Publication Date Title
MX2017015674A (es) Suplemento dietetico.
WO2016086205A8 (en) Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome
MX2021007668A (es) Composiciones que comprenden cepas bacterianas.
CO2018010954A2 (es) Nuevo uso médico de probioticos
MD3359172T2 (ro) Compoziții care conțin tulpini bacteriene
EP3536168A3 (en) Probiotic formulations and methods for use
PH12015502401A1 (en) Compositions and methods for enhancing microbial stability
AU2019263623A8 (en) Probiotic Bifidobacterium breve strain and compositions comprising said strain
AR106385A1 (es) Composición cosmética que comprende bacterias probióticas
PT3412766T (pt) Estirpe lactobacillus salivarius, composição que compreende a mesma e suas utilizações
MX383749B (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas
MX2017016748A (es) Bacteria lactobacillus rhamnosus para el tratamiento de, por ejemplo, vaginosis bacteriana.
MX2017006701A (es) Fórmula infantil con rrr-alfa-tocoferol,2'-fucosilactosa y un probiótico.
MX2022007775A (es) Composición para usarse en terapia de microbiota.
PH12020550217A1 (en) Nutrient-spore formulations and uses thereof
SG11201608730UA (en) Bifidobacterium breve cbt br3 strain for promotion of growth and nutraceutical composition for promotion of growth containing the same
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
PH12018501822A1 (en) Immune development accelerator
PH12019550209A1 (en) A nutritional composition for use to enhance attention and/or reduce impulsivity
MX2021004150A (es) Composiciones que comprenden cepas bacterianas.
CL2018001680A1 (es) Composiciones y métodos de uso de nuevas cepas de lactobacillus fermentum
FI20096400A0 (fi) Veriryhmästatuksen käyttö I
CY1124623T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
UY35631A (es) ?composición de solución de rehidratación oral que contiene probióticos?.
CL2020001958A1 (es) Composición que comprende nuevas cepas de lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas.